Ptc Therapeutics (PTCT) Gross Profit (QoQ) (2016 - 2026)

Ptc Therapeutics (PTCT) Gross Profit (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn
9 Revolution Medicines 37.76 Bn 37.76 Bn -
10 Ptc Therapeutics 6.42 Bn 4.53 Bn 244.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.03%
Dec 31, 2025 -19.21%
Sep 30, 2025 16.58%
Jun 30, 2025 -85.60%
Mar 31, 2025 490.81%
Dec 31, 2024 5.89%
Sep 30, 2024 1,297.51%
Jun 30, 2024 -107.95%
Mar 31, 2024 -29.70%
Dec 31, 2023 48.56%
Sep 30, 2023 -6.96%
Jun 30, 2023 -2.50%
Mar 31, 2023 31.77%
Dec 31, 2022 -22.94%
Sep 30, 2022 30.30%
Jun 30, 2022 12.47%
Mar 31, 2022 -11.10%
Dec 31, 2021 17.93%
Sep 30, 2021 20.94%
Jun 30, 2021 0.44%